다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of hepatology : the journal of the European Association for the Study of the Liver, v.27 no.1, 1997년, pp.143 - 149
González-Koch, Alvaro (Gastroenterology Center, University of Chile Clinical Hospital, Santiago, Chile) , Brahm, Javier (Correspondence: Javier Brahm, MD, Hospital Clí) , Antezana, Cristina (nico Universidad de Chile, Santos Dumont 999. Independencia, Santiago, Chile. Tel: (56-2) 678-8350. Fax: (56-2) 217-2998.) , Smok, Gladys (Gastroenterology Center, University of Chile Clinical Hospital, Santiago, Chile) , Cumsille, Miguel A. (Department of Pathology, University of Chile Clinical Hospital, Santiago, Chile)
AI-Helper
Abstract Background/Aims: Many therapies have been tried in primary biliary cirrhosis. It has been suggested that a combination of ursodeoxycholic acid and methotrexate may offer advantages. Because the benefit and safety of this combination is uncertain, we conducted this prospective, randomized,...
Lancet Poupon i 834 1987 10.1016/S0140-6736(87)91610-2 Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
N Engl J Med Poupon 324 1548 1991 10.1056/NEJM199105303242204 A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis
N Engl J Med Poupon 330 1342 1994 10.1056/NEJM199405123301903 Ursodiol for the long-term treatment of primary biliary cirrhosis
Ann Intern Med Kaplan 109 429 1988 10.7326/0003-4819-109-5-429 Primary biliary cirrhosis treated with low-dose oral pulse methotrexate
Hepatology Kaplan 16 92A 1992 The Therapeutic effects of ursodiol and methotrexate are additive and well tolerated in primary biliary cirrhosis
J Hepatol Buscher 18 9 1993 10.1016/S0168-8278(05)80004-2 Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone
Hepatology Lindor 22 1158 1995 The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study
Virchows Arch Pathol Anat Ludwig 379 103 1978 10.1007/BF00432479 Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Gastroenterology Portmann 88 1777 1985 10.1016/0016-5085(85)90001-0 Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients
Hepatology Dickson 10 1 1989 10.1002/hep.1840100102 Prognosis in primary biliary cirrhosis: model for decision making
N Engl J Med Roll 308 1 1983 10.1056/NEJM198301063080101 The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis
Gastroenterology Christensen 105 1865 1993 10.1016/0016-5085(93)91086-W Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model
Hepatology Locke 23 52 1996 10.1002/hep.510230108 Time course of histological progression in primary biliary cirrhosis
Hepatology Wiesner 8 668 1988 10.1002/hep.1840080339 Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis
Hepatology Jones 21 1469 1995 Ursodeoxycholic acid therapy in primary biliary cirrhosis
Lancet Goddard 343 1305 1994 10.1016/S0140-6736(94)92461-9 Primary biliary cirrhosis: how should we evaluate new treatments? (letter)
Gastroenterology Kaplan 101 1332 1991 10.1016/0016-5085(91)90085-Y Treatment of primary biliary cirrhosis with low-dose weekly methotrexate
GEN Findor 46 250 1992 Comunicacion preliminar del tratamiento a largo plazo con acido ursodesoxicolico (UDCA) en la cirrosis biliar primaria
J Hepatol Attili 20 315 1994 10.1016/S0168-8278(94)80001-4 The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind, placebo-controlled trial
J Hepatol Bellentani 19 459 1993 10.1016/S0168-8278(05)80558-6 Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial
Eur J Clin Pharmacol Rolandi 40 5 473 1991 10.1007/BF00315225 Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study
Hepatology Crosignani 13 339 1991 10.1002/hep.1840130222 Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study
J Hepatol Leuschner 25 49 1996 10.1016/S0168-8278(96)80327-8 Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis
Dermatologica Zachariae 175 178 1987 10.1159/000248822 Methotrexate-induced liver cirrhosis: a follow-up
Cleve Clin Q Mackenzie 52 129 1985 10.3949/ccjm.52.2.129 Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis
J Rheumatol Rau 16 489 1989 Liver biopsy findings in patients with rheumatoid arthritis undergoing long-term treatment with methotrexate
Gastroenterology Hoofnagle 101 1440 1991 10.1016/0016-5085(91)90100-Y Methotrexate therapy for primary biliary cirrhosis: promising but worrisome
Q J Med Sherlock 87 701 1994 Therapeutics trials in primary biliary cirrhosis
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.